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In this paper we demonstrate the possibility of modifying porous silicon (PSi)
particles with surface chemistry and recognition molecules (antibodies) such that
these devices could potentially be used for single-cell identification or sensing.
This is achieved by modifying PSi Rugate filters via hydrosilylation with surface
chemistry that serves firstly, to protect the silicon surfaces from oxidation;
secondly, renders the surfaces resistant to nonspecific adsorption of proteins and
cells and thirdly, allows further functionality to be added such as the coupling of
antibodies. The surface chemistry remained unchanged after sonication of the PSi
to form PSi microparticles. The ability to monitor the spectroscopic properties of
microparticles, and shifts in the optical signature due to changes in the refractive
index of the material within the pore space, is demonstrated. The particles are
shown to remain stable in physiological buffers and human blood for longer than
one week. Finally, the modification of the PSi particles with functional antibodies
is achieved.
1 Introduction
Porous silicon (PSi) is a particularly versatile material having found applications in
photonic devices,1 electrodes,2 sensor systems3 and drug-delivery devices.4,5 Hence
PSi also has potential to be applied in theranostics. Mesoporous silicon, where pores
are in the size range of 2–50 nm, is the most relevant material for these applications.
It is most commonly prepared by anodically etching the silicon in hydrofluoric acid
(HF) in, effectively, a corrosion reaction,2 where the silicon is first oxidised and the
resultant SiO2 is then dissolved away in the HF. Remarkably, under many condi-
tions the corrosion commences at a nucleation site on the silicon surface and
proceeds linearly through the material to result in a columnar pore. Importantly
for the above-mentioned applications, the size of the pore, and hence the extent of
porosity, can be easily tuned by controlling the current density, and hence the disso-
lution rate,6 during formation. That is, the exquisite control over reactivity that elec-
trochemistry provides is directly translated into the same exquisite control over the
material’s structure. It is this ability to control and alter porosity, and pore size, with
nanoscale resolution as the PSi is being fabricated that allows one-dimensional
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photonic crystals, with complicated multilayer structures, to be produced. High-
quality optical structures such as Bragg reflectors,7 microcavities8 and Rugate filters9
have been produced from PSi.
It is the optical structures formed from PSi that sees this material applied to
sensing. The optical signature of the photonic crystals is sensitive to the average
refractive index of the structure. Therefore, in sensing, the adsorption of material
to the pore walls will cause a red-shift (to longer wavelengths) if it has a higher
refractive index than the material it replaces because the average refractive index
of the structure increases. Similarly, if this material desorbs from the pore walls,
the average refractive index decreases, and there is a concomitant blue-shift (to
shorter wavelengths). By modifying the pore walls with the appropriate surface
chemistry, PSi photonic crystals can be turned into label-free optical detectors
with the required selectivity for the analyte of interest.3
Apart from being a label-free system, PSi photonic crystals are particularly attrac-
tive for biosensing as the optical signature can be tuned, via changes in the porosity
and periodicity of the multilayer photonic crystals, over the entire visible and
infrared regions of the electromagnetic spectrum. Tuning the optical signature to
the near-IR between 700–1000 nm is particularly attractive as transmission through
tissue is then possible10 and hence PSi may be amenable to implantable devices for
non-invasive interrogation. Another aspect of PSi that makes it attractive for use in
biological systems, such as in vivo applications, is that PSi has been shown to degrade
in aqueous solution to orthosilicic acid by the following mechanisms:11
Si(s) + 2H2O(l) / SiO2(s) + 2H2(g)
SiO2(s) + 2H2O(l) / Si(OH)4(l)
As orthosilicic acid is the natural form of silicon found in the body it can be
readily excreted via the kidneys12 and has been shown to elicit a limited foreign
body response that is comparable to titanium surfaces when implanted in rats.4,13
Hence implanted devices will eventually degrade away and not require surgical
removal. It is the degradation that sees PSi used as a material for drug delivery of
poorly solubilised drugs.4,5 With the drug incorporated into the pore space of the
PSi, the effective solubility of poorly soluble drugs is increased while the degradation
of the PSi in biological fluids enables controlled release of the drug. The issue here is,
however, that the degradation of freshly etched PSi is rapid (within hours).14 To slow
the degradation down requires chemical modification of the PSi.
There are two main surface chemistries employed for the chemical modification of
the PSi. One strategy is to thermally oxidise the PSi and then use classical silane
chemistry.3,15 This chemistry however does not effectively passivate the PSi from
degradation in aqueous solutions and is prone to hydrolysis itself. Further, it is diffi-
cult to determine whether monolayers or multilayers have been formed.3 The other
common strategy is to exploit the fact that the freshly prepared PSi presents
a hydrogen-terminated silicon surface. Linford and Chidsey16,17 showed that alkenes
and alkynes could be reacted with such surfaces to give very stable monolayers on
silicon without an intervening oxide layer (Scheme 1). This surface chemistry does
not suffer from the drawbacks of silane chemistry but it is challenging to modify
silicon with this surface chemistry without some oxide forming.18 Any oxide present
will then cause the PSi to degrade in aqueous solution.14,19,20 With regard to sta-
bilising PSi for drug delivery, Canham and co-workers21 showed that using the hy-
drosilylation of dodecene to modify PSi the material showed little degradation
over four weeks. Note however, that as dodecene renders the material hydro-
phobic, part of the reason for the excellent stability enhancement is that little

















































or no water penetrates into the pore space. More recently, we have shown that
degradation is much more rapid in plasma if the modifying layer formed via hy-
drosilylation is hydrophilic.14,19 However, the use of hydrophilic surface chemistry
that resists protein adsorption, enhances the stability of PSi in plasma and biolog-
ical buffers markedly. Modifying a PSi photonic crystal using undecenoic acid fol-
lowed by the addition of an hexa(ethylene oxide) antifouling moiety allowed
optical signatures from the photonic crystals to be recorded even 60 days after
immersion in biological buffer.14 Furthermore, we have shown that the degrada-
tion rate of PSi can be controlled by subtle variations in the coverage of the
organic molecules attached to the PSi.18
Surface chemistry similar to that described above has also been crucial in our
efforts to turn PSi photonic crystals into biosensors.3 For biosensors, the surface
chemistry is required not only to stabilise the device but also to give the photonic
crystal the selectivity for the target analyte. Initial studies into using PSi for biosens-
ing focussed on affinity sensors for the detection of DNA,22,23 proteins22,24,25 and
microorganisms.26 However, more recently there has been a trend to use PSi
photonic-crystal-based biosensors for detecting enzymatic activity, specifically
protease enzyme activity.20,27–32 The focus of interest on protease enzymes was moti-
vated by the importance of this class of enzyme in natural processes such as cell
migration and tissue remodelling, as well as acting as a marker of many pathologies
and infection, where early detection is often critical.33
Our main aim is to detect protease activity and hence cell activity for the develop-
ment of responsive cell chips for diagnostic and theranostic purposes. Macrophage
and other immune cells respond to environmental stimuli, such as chemical cues,
chemokines, and the presence of foreign species, by releasing granules containing
a high concentration of protease enzymes. The enzymes remodel the surrounding
extracellular matrix, often leading to substantial tissue damage. Hence, monitoring
the activity, and not just the presence of, protease enzymes serve as an excellent
extracellular marker of the response of cells to their environment, of immune
responses and cell activities that underlies a pathology.34–36 To develop a chip that
Scheme 1 A general representation of the hydrosilylation reaction used to modify hydrogen-
terminated silicon surfaces with alkenes or alkynes with heat or UV light.
Fig. 1 PSi photonic crystals detect secretion of gelatinase enzymes. A) Human monocyte
derived macrophages stained for actin adhere uniformly to gelatin coated PSi. B) After 24 h
of lipopolysaccharide (LPS) stimulation the photonic resonance of the Rugate filter blue-shifts
8 nm, indicating digestion of the pore-encapsulated polypeptides.

















































can monitor protease release from specific cells requires a material that can capture
the cells and, at the same time, monitor the release of protease enzymes from cells
with the required sensitivity. This is where PSi comes in.
Using PSi we have 1) developed the surface chemistry to stabilise this material in
biological buffers and plasma,14,19,20 2) shown that we can detect protease activity by
attaching peptide substrates, for the protease enzymes, to the pore walls of the
PSi,20,27 3) demonstrated that cell adhesion ligands can be attached onto the exterior
of a PSi photonic crystal while different chemistry can be attached to the internal
pores37,38 and 4) that the release of protease enzymes from live cells captured onto
the PSi surface could be detected via degradation of a gelatin substrate immobilised
inside the pores of the PSi.28,39 The types of data obtained using these four develop-
ments are shown in Fig. 1.
Here we used Rugate filters. Rugate filters are a class of photonic bandgap struc-
tures with a periodic sinusoidal refractive index profile. They are formed in PSi by
modulating the porosity of the film on the sub-micrometre scale during etching.
The structures are characterised by a spectral band of high reflectivity where the
central wavelength (l) is given by l ¼ nd, where n is the average refractive index
and d is the physical thickness of each period. The width of the reflectivity is propor-
tional to the amplitude of the refractive index modulation, and for small variations,
the reflectivity band can be very sharp; of the order of 10 nm. Importantly, the cor-
responding porosity modulation means there is very little variation in porosity
across a photonic crystal. For example, with the photonic crystals used in Fig. 1,
the porosity varied between 64 and 66%, with pore diameters of 50 nm.27 This essen-
tially means the pore size is virtually unchanged through the structure and hence
there will be little variation in the rate of mass transport of enzymes throughout
the structure.
Fig. 1 shows the power of using these engineered PSi photonic crystals for cell
chips. The adherence of human monocyte derived macrophages (HMDMs) to the
PSi substrate is shown in Fig. 1A where cells are well spread on the substrate.
Fig. 1B shows the change in the optical signature of the photonic crystals as a result
of the release of matrix metalloproteases (MMPs) from the HMDMs. These optical
responses are obtained from an estimated 1500 cells.39 The blue-shift in the optical
signature is a result of degradation of gelatin from the pores of the PSi, with
lower-refractive-index water (n  1.3) replacing the higher-refractive-index gelatin
(n  1.4). An increased response was seen as a larger blue-shift when the cells
were exposed to LPS (a lipopolysaccharide found on the exterior of gram-negative
bacteria) because the LPS triggers the release of MMP-2 and MMP-9 which are
both gelatinases.40,41 The number of cells that give the response shown in Fig. 1B
was a consequence of the size of the footprint of the light source used to acquire
the data rather than the sensitivity of the device. The measured sensitivity is actually
determined by the proportion of pores in which gelatin was degraded and it was
demonstrated that degradation of gelatin in only 1 in 30 pores is easily observed.28
Hence, reducing the area of spectral collection down to the micrometre range should
allow single-cell measurements to be performed.
The purpose of the present paper is to outline the progress made towards single-
cell sensing using PSi Rugate filters. To achieve this in cell culture, we decided to
form PSi microparticles and make them selective for specific cell types by modifying
the particles with antibodies. The fabrication of PSi microparticles has most
commonly been done by using a high current pulse to lift-off a PSi photonic crystal
from the silicon wafer in which it was formed, and then shatter it into small pieces via
sonication.42–44 The PSi pieces have a broad distribution of sizes in the micrometre
range of 4 to 80 mm (Figs. S1 & S2 of the ESI†). Extending our previous work on
detecting protease activity in single-cell sensors requires a number of questions to
be answered. These are: 1) Can we measure optical signatures from single particles
and how reproducible are they? 2) How do we modify particles with surface chem-
istry to stabilise them and incorporate selectivity for a target analyte? An important

















































part of this question is to work out the sequence of fabrication steps e.g. is the
protective surface chemistry best performed before the high current pulse in HF
that is necessary to cause the lift-off from the silicon crystal, after lift-off but before
formation of particles or after the formation of the particles? 3) How stable will the
particles be in aqueous solution and biological buffers and how will the surface
chemistry influence this? and 4) Can the particles be modified with antibodies




All chemicals, unless noted otherwise, were of analytical grade and used as received.
Chemicals used in surface modification procedures were of high purity ($ 99%).
1,8-Nonadiyne (Alfa Aesar, 97%) was redistilled from sodium borohydride (Sigma-
Aldrich, 99+%) under reduced pressure (79 C, 8–9 Torr) and collected over acti-
vated molecular sieves (Fluka, 3 A pore diameter, 10–20 mesh beads, dehydrated
with indicator), and stored under a dry argon atmosphere prior to use. MilliQ
water (>18 MU$cm) was used to prepare solutions and for chemical reactions. Di-
chloromethane, ethanol, and ethyl acetate for surface cleaning, chemical reactions
and purification procedures, were redistilled prior to use. Dry acetonitrile was ob-
tained from PureSolv MD 7 Solvent Purification System (Innovative Technology,
Inc., Galway, Ireland). The azide compounds, 1-azido-octane and 11-azido-3,6,9-
trioxaundecan-1-ol were synthesized as described previously.38 Prime grade single-
side polished silicon wafers, 100-oriented (<100>  0.05), p-type (boron), 350 
25 mm thick, 0.069–0.077 U$cm resistivity, were obtained from M.M.R.C Pty.
Ltd. (Malvern, VIC, Australia).
The antibodies, Cy3 AffiniPure donkey anti-rabbit IgG (H + L), Cy3 AffiniPure
donkey anti-goat IgG (H + L) and Cy3 AffiniPure donkey anti-mouse IgG (H + L)
were all purchased from Jackson ImmunoResearch (West Grove, PA, USA). Mouse-
hosted FITC anti-human CD3 primary antibody was obtained from eBioscience
(San Diego, USA).
2.2 Fabrication of porous silicon lift-off films
Rugate filters with 60 periods of low and high refractive index layers were prepared
in a custom-made electrochemical cell with 1 : 1 by volume solution of 48% hydro-
fluoric acid/99% ethanol as described in ref. 9. A current density varying between
42 mA$cm2 and 124 mA$cm2 was applied periodically to afford a porous structure
with a porosity variation from 54% to 64% and an average pore size of 20 nm (see
Fig. S4†). After etching, a high current pulse (11.3 mA$mm2) was employed to lift
the PSi structure off the substrate (but with the circumference of the PSi remaining
attached to the substrate) with 1 : 2.3 by volume solution of 48% hydrofluoric acid/
99% ethanol. The lift-off wafer was then rinsed with ethanol and pentane and dried
with argon.
2.3 Chemical modification of porous silicon lift-off films
Stepwise modification of the PSi Rugate filter lift-off films followed a previously re-
ported procedure.38 Briefly, freshly etched filters were modified with neat 1,8-nona-
diyne in a dry argon atmosphere at 170 C for 3 h to form acetylene monolayers on
the surface. The filters were then placed in a typical ‘‘click’’ reaction mixture consist-
ing of: 1) the azide compound (10 mM, ethanol/water, 1 : 1 v/v); 2) copper(II) sulfate
pentahydrate (1 mol % relative to the azide); 3) sodium ascorbate (25 mol % relative
to the azide) for further modification. In the absence of a Cu(I)-stablizing ligand,
N,N,N0,N0-tetramethylethane-1,2-diamine (TMEDA), the lift-off samples were func-
tionalized with 11-azido-3,6,9-trioxaundecan-1-ol for 19 h to form tetra(ethylene

















































glycol) (EO4) terminated surfaces on the exterior only. Modification of the interior
pore surface with either 1-azido-octane or 11-azido-3,6,9-trioxaundecan-1-ol was
followed an analogous procedure, but with 0.5% (v/v) TMEDA in the ‘‘click’’
mixture to afford either an octyl- or an EO4-terminated interior. After each modifi-
cation step, the PSi films were rinsed consecutively with ethanol and ethyl acetate
and blown dry under a gentle stream of argon before further reaction.
2.4 Engineering of porous silicon microparticles
The PSi lift-off samples with different functionalities on the exterior and interior
were floated off the substrate and placed in a 2-mL eppendorf tube with 1 mL
ethanol for sonication. PSi microparticles in the size range of 4–80 mm were engi-
neered in a Misonix Sonicator 2000 with a Microtipt probe (Qsonica, LLC.
USA) at the energy of 266 J (amplitude 30) for 1 min with one repeat. The particles
were dried under vacuum and stored under argon for further use.
2.5 Porous silicon microparticle stability test
Porous silicon microparticles at the size of around 10 mm were incubated in phos-
phate buffered saline (1 PBS, pH 7.4), Dulbecco’s Modified Eagle Medium
(DMEM) or a white blood cell concentrate from human blood (composed of mostly
leukocytes and platelets and referred to as ‘buffy coat’) (diluted 1 : 5 v/v with 1
PBS) at 37 C in 5% CO2, while reflectivity measurements and epi-illumination
micrographs were taken over time in solution.
2.6 Antibody functionalities on PSi particles
Tetra(ethylene glycol) EO4-terminated PSi microparticles were placed in a reaction
tube containing: a) N,N0-disuccinimidyl carbonate (DSC, 0.1 M) and b) N,N-dime-
thylaminopyridine (DMAP, 0.1 M) in dry acetonitrile for 20 h in the presence of
activated molecular sieves (3 A). The succinimidyl-terminated particles were rinsed
with ethyl acetate and dichloromethane and then transferred to an antibody solution
(1 : 500 v/v) in 1 PBS for 1 h at room temperature. Antibody-coupled PSi particles
were then rinsed with MilliQ water and 1 PBS washing buffer with 0.5% (v/v)
Tween 20 (Sigma-Aldrich) and stored in 1 PBS for antibody functional tests.
Antibody functionality tests were conducted in two ways: 1) to test the ability of
antibodies to recognise protein-modified particles. Here, PSi microparticles were
coated with mouse anti-human CD3 IgG-FITC and then incubated with either
anti-goat IgG-Cy3 (1 : 500 v/v in 1 PBS) or with anti-mouse IgG-Cy3 (1 : 500
v/v in 1 PBS), respectively, for 1 h at room temperature; 2) to explore whether anti-
body-modified particles selectively bind to protein markers. PSi microparticles
were coated with anti-rabbit IgG-Cy3 or with anti-mouse IgG-Cy3. The modified
PSi particles were then incubated with mouse anti-human CD3 IgG-FITC-
(1 : 500 v/v in 1 PBS). The particles were then rinsed twice with 1 PBS washing
buffer (0.5% (v/v) Tween 20), followed by 1 PBS and stored in 1 PBS at 4 C for
fluorescence imaging.
2.7 Optical and surface characterisation
Optical reflectivity spectra of the microparticles were measured in the visible and
near-IR at normal incidence using a custom-built optical arrangement on an in-
verted Leica DM IL LED microscope (Leica Microsystems Pty Ltd, USA). In this
set-up a USB2000+ miniature fiber optic spectrometer (Ocean Optics Inc., USA),
having a spectral resolution of 1 nm, was coupled to a multimode fibre with the col-
lecting facet mounted in the conjugate image plane of the microscope. The micro-
scope was equipped with a N PLAN L 40/0.55 air objective, an epi-illumination
brightfield slider and a ProgRes CFscan camera (JENOPTIK Laser, Optik,

















































Systeme GmbH, Germany) for capturing the reflectance images of particles. The col-
lecting aperture of the fibre-coupled spectrometer had a diameter of 100 mm which
corresponded to an effective collecting spot of approximately 3 mm at the sample
plane. Reflectivity spectra were recorded and processed using the SpectraSuite spec-
troscopy software platform (Ocean Optics Inc., USA).
Fluorescence images of particles in antibody function tests were obtained with the
same Leica microscope, fitted with a mercury short-arc reflector lamp. FITC-fluores-
cence was detected with a excitation filter: BP470/40, a dichroic mirror: 500 and
a emission filter: 525/50. Cy3 fluorescence was detected with a excitation filter:
BP545/50, a dichroic mirror: 565 and a emission filter: 610/75. The images were re-
corded with the ProgRes Capture Pro 2.7 software (JENOPTIK Laser, Optik, Sys-
teme GmbH, Germany) and processed with ImageJ 1.42q (National Institutes of
Health, USA).
The Spotlight 400 Fourier transform infrared spectroscopy (FTIR) microscope
system was from PerkinElmer and was used to record transmission FTIR spectra
from single PSi particles. The particles were vacuum dried and mounted on a KCl
disc. The spectra were then collected at the resolution of 2 cm1 and an average of
128 scans with a light aperture of 45  45 mm.
Scanning electron microscopy (SEM) images were taken using a Hitachi S900
SEM with a cold-field emission source (4 kV). PSi microparticles were mounted
on a brass sample base using carbon tape.
3 Results and discussion
3.1 Formation of porous silicon nanoparticles and their reflectivity spectra
Rugate filters were fabricated in single crystal, p-type, Si(100) with 60 layers and
a pore size of 20 nm. After preparation, a high current pulse was used to cause a frac-
ture between the crystalline silicon and the PSi sample. However, the lateral edges of
the PSi remain attached to the silicon crystal. It is this partially attached PSi sample
that is modified prior to particle formation according to scheme S1† as discussed
below. After surface modification, the PSi lift-off sample was completely removed
from the silicon crystal and converted into particles. After particle formation, it
was important to demonstrate that reflectance spectra of individual particles could
be monitored and that each particle from a batch exhibited a similar reflectivity spec-
trum. To take spectra of single particles, a normal epi-fluorescent microscope was
Fig. 2 a) Epi-illumination bright-field images of ethylene glycol modified PSi particles after
sonication and b) reflectivity spectra of PSi particles from the same modified PSi film, featuring
a high reflectivity peak at 547  3 nm (mean  SD).

















































employed where a collecting optical fibre mounted at the conjugate image plane in
the camera port was used to record spectral data. The types of epi-illumination
images of the particles and the reflectivity spectra of these particles are shown in
Fig. 2.
As is evident from Fig. 2 there is some variation in the colour and spectra of these
particles. This variation arises from slight differences in the fabrication of the
Rugate filter across the sample due to uneven distribution of electrical field lines
during the fabrication of the PSi. Importantly however, the optical properties are
not significantly altered during sonication of the lift-off PSi sample to form particles.
3.2 Modification of porous silicon microparticles via hydrosilylation
Rather than first forming the particles and then modifying them, it was decided to
use a high current pulse to partially detach the PSi from the silicon crystal on which
it was formed and then modify the PSi before sonication, according to Scheme S1 of
the ESI.† The reason for this was ease of handling but it did mean 1) that there
would be unmodified silicon where the silicon was fractured and 2) that the surface
chemistry was required to be capable of surviving the high energy of the sonication.
As shown in Scheme S1 the PSi structure is first modified with the dialkyne, 1,8-non-
adiyne, in an inert atmosphere at 170 C for three hours. Subsequently, further func-
tionality is added by reacting an azide-bearing moiety with the distal alkyne in the
presence of a Cu(I) catalyst via the Huisgen 1,3-dipolar cycloaddition reaction; the
archetypal ‘click’ reaction. It has been shown previously that this surface chemistry
provides excellent protection of the underlying silicon surface from oxidation, even
under anodic potentials,45 with both flat silicon46 and PSi.47 We note that in our
hands it was much easier to produce good protection of PSi from oxidation using
this 1,8-nonadiyne than the chemistry we used previously that employed undecenoic
acid.3 Furthermore, although unnecessary on flat silicon, for the ‘click’ reaction to
proceed within mesoporous silicon requires the complexation of the Cu(I) catalyst
with a N,N,N0,N0-tetramethylethane-1,2-diamine ligand for the reaction to proceed
inside the pores.47 This observation was used to modify PSi with completely different
chemistry inside the pore space relative to the exterior surface38 as shown using
optical reflectivity, X-ray photoelectron spectroscopy (XPS) and transmission Four-
ier transform infrared (FTIR) spectroscopy.2 Using this strategy, the exterior surface
was modified with an azido tetra(ethylene glycol) to render the external surface resis-
tant to nonspecific protein and cell adsorption but also to allow further attachment
Fig. 3 Comparison of FTIR spectra of porous structure modified with alkyne monolayers and
EO4 moieties inside and out in lift-off PSi films (a) before sonication, and (b) in PSi particles
after sonication.

















































of biomolecules to the alcohol terminus of this molecule as described previously.48
The internal pore surfaces were then modified with the same tetra(ethylene glycol)
species to make the internal surface hydrophilic, such that water will easily penetrate
the pores, and to allow attachment of the gelatin substrate required by matrix metal-
loprotease enzymes secreted from macrophage cells (MMP-2 and MMP-9). Alterna-
tively the internal pores were modified with an octane species to make the internal
volume hydrophobic.37 The reason for this modification was to explore whether
better stability of particles in biological media was achieved if the ingress of aqueous
solution into the material was limited.
After modifying the PSi with the base 1,8-nonadiyne layer followed by clicking on
different functionality to the internal and external surfaces, the PSi disk was cut from
the silicon crystal and sonicated in ethanol to give micrometre-size particles. To show
the surface chemistry was not altered by the highly energetic conditions of sonication
transmittance FTIR was performed before and after the sonication step (Fig. 3).
Fig. 3a shows the asymmetrical and symmetrical stretching of the CH2 group at
2925 cm1 and 2852 cm1 remains unchanged. The broad OH stretch in the range
3500–3200 cm1 and C–O stretching vibration at 1150 cm1 support the presence
of ethylene glycol moieties on the surface. Also present are the bands at 1630 cm1,
1455 cm1 and 1350 cm1, ascribed to Si–C]C stretching, CH2 scissoring and C–N
bond respectively, strongly supporting a complete surface modification on PSi parti-
cles. Significantly, there is no broad band around 1150 cm1 which would be indic-
ative of any silicon oxide, thus indicating the effectiveness of the surface chemistry
at modifying the silicon without any silicon oxides being formed. Most impor-
tantly however, Fig. 3a and b show no discernable difference indicating the soni-
cation did not cause any harm to the surface chemistry. Similar results are
Fig. 4 PSi particles with hydrophilic and hydrophobic internal functionalities in dry/wet
conditions. (a) Reflectivity spectra of a single hydrophilic particle in air and in phosphate-
buffered saline (PBS). A color change from green (i) to red (ii) in the same hydrophilic particle
can be observed. (b) Reflectivity spectra of a hydrophobic particle in air and in PBS. The insets
(iii) and (iv) show the illumination images of hydrophobic particles in dry and wet conditions,
respectively. Scale bar equals 50 mm.

















































observed when the internal surface chemistry is terminated with octyl moieties
(see Fig. S3 of the ESI†).
The effectiveness of the surface modification in controlling the way the particles
interacted with aqueous solution, and hence a demonstration of the ability to place
different surface chemistry on the inside and outside of the PSi particles, was demon-
strated using reflectivity measurements. The particle with internal octane-termina-
tions are expected to exclude water from penetrating into the pores, while with
a hydrophilic group, e.g. ethylene glycol, the pores are expected to be filled with
water. As water has a higher refractive index than the air it replaces, the penetration
of water into the structure will result in a red-shift in the reflectivity peak to longer
wavelengths. Photonic crystals with reflectivity bands in the visible region were em-
ployed for this purpose so the changes could also be seen visually (Fig. 4). Fig. 4a
shows a 30 nm spectral shift in the reflectivity spectrum caused by water infiltration
and the two inset graphs [(i) & (ii)] display an abrupt color change of the same
particle. No significant spectral shift in Fig. 4b suggests a well-passivated hydro-
phobic surface in the pores of PSi particles, which resist infiltration of water into
the pore spaces.
3.3 Stability of PSi particles under physiological conditions
The next step was to evaluate the different particles, those with hydrophilic modifi-
cation inside the pores and those with hydrophobic surface chemistry, for their
stability in physiological media. We have performed such studies for similar hydro-
philic surface chemistry with porous silicon still incorporated within the single
crystal silicon and showed that PSi structures gave recognisable optical signatures
for up to 60 days incubation in PBS buffer at 37 C.14,19 The particles however
may have significantly lower stability because the fabrication of the particles exposed
unmodified silicon that could then act as the site where degradation begins. The eval-
uation of the influence of physiological condition, and potentially an in vivo environ-
ment, on the PSi particles were performed in three different solutions: PBS, cell
culture medium DMEM and diluted human blood buffy coat at physiological
temperature and pH for up to 23 days.
Fig. 5 shows the reflectivity stop-band shift of PSi particles with hydrophobic
octane groups inside the pores incubated in PBS (a), DMEM (b) and diluted
human blood buffy coat (c), respectively. As there is some variation in optical
properties between particles, for each time point more than 10 particles were eval-
uated and the spectral data from all particles are included in the figures. It is also
important to recognise that the data at each time point come from the same pop-
ulation of particles but, as it is difficult to identify individual particles, the data at
each time point does not necessarily come from the same particles as previous time
points. What is apparent from all three media is that there is a red-shift of the
reflectance band after a few hours which indicates water is penetrating the pores
despite the pore surface chemistry being hydrophobic. This suggests that any
protection of the particles from degradation will arise from the surface chemistry
rather than the exclusion of water. After the initial red-shift, however, the central
wavelength of the reflectivity peak remained statistically the same for up to 11 days
in PBS and human blood. In the case of the cell culture medium, DMEM, the
optical properties of the particles remain stable for 7 days whereupon a blue-shift
in the reflectivity peak appears to suggest the particles are beginning to degrade,
although distinct optical signatures are still easily discernable after 23 days. Also
shown in Fig. 5b are optical micrographs of particles at different times during their
incubation in the DMEM to visually illustrate the change in optical properties of
particles.
The PSi particles functionalized with hydrophilic ethylene glycol moieties were
also evaluated for stability in the same three media: PBS, DMEM and human blood
buffy coat (Fig. 6). Unlike the hydrophobic particles there was no initial red-shift in

















































the reflectivity as the pore spaces of the particles were already filled with water. A
gradual blue-shift in the position of the reflectivity band, presumably due to oxida-
tion of the silicon and hence a degradation of the particles, was observed after two-
day incubation in PBS (Fig. 6a). Similar results were shown for incubations in
DMEM in Fig. 6b with the blue-shift becoming statistically significant after four
Fig. 5 Stability of the high reflectivity peak position for PSi particles with hydrophobic
internal pores exposed to PBS (a), DMEM (b) and diluted human blood buffy coat(c) over
time. The asterisks stands for the significance level of variances relative to the starting point
(time 0) based on one-way ANOVA analysis: *** (99.9% confidence), ** (99% confidence)
and * (95% confidence). The insets are illumination images of PSi particles at different incuba-
tion times in DMEM.

















































days. In blood, Fig. 6c, the blue-shift, indicative of particle degradation, only
became significant after more than one week. For comparison, the same stability
tests were also performed on particles with hydrophilic interiors and exteriors, as
in Fig. 6, but for particles with optical signatures tuned in the near-IR (the ‘tissue
window’). The near-IR particles showed virtually identical behaviour to those in
Fig. 6 above (see Fig. S4 of the ESI†).
The stability studies were very encouraging as they show there is no major degra-
dation of particles within the first few days of exposing them to physiological media
which is well beyond the expected operation time for most diagnostic and
Fig. 6 Stability of the high reflectivity peak position for PSi particles with hydrophilic internal
pores exposed to PBS (a), DMEM (b) and diluted human blood buffy coat (c) over time. The
asterisks stands for the significance level of variances related to the start point (time 0) based on
a one-way ANOVA analysis: *** (99.9% confidence), ** (99% confidence) and * (95% confi-
dence).

















































theranostic applications. Furthermore, it is clear that the particles will still provide
some optical information for 23 days after application.
3.4 Antibody immobilization on PSi microparticles
The final questions explored in this study were whether particles could be modified
with antibodies on the external surface and whether the antibodies maintained their
functionality? Initial attempts to modify the exterior surface of the PSi with anti-
bodies prior to sonication of the PSi lift-off sample to form the microparticles re-
sulted in destruction of the antibodies. As a consequence, modified PSi particles
were first prepared with a hydrophobic internal pore surface chemistry and a tetra
(ethylene glycol) species on the external surface as shown in Scheme 2. The lift-off
PSi was then sonicated to form particles; a process shown above not to affect the
surface chemistry. The distal alcohol moieties on the tetra(ethylene glycol) were con-
verted to succinimide esters using DSC/DMAP,48 which then allows covalent
coupling of amines such as those found on lysine residues of antibodies (Scheme 2).
A fluorescence labeled antibody, cyanine 3 affiniPure donkey anti-mouse IgG (H +
L) was chosen to test the antibody immobilization by examining its fluorescence under
the Leica microscopy. The immobilization steps were further monitored using a trans-
mission-mode FTIR microscope that was able to measure spectra from each single
microparticle.
FTIR spectra obtained from ethylene glycol-terminated PSi particles, DSC-activated
and antibody-coupled particles are shown in Fig. 7. The presence of na(CH2), ns(CH2),
d(CH2), n(C–N) and n(C–O–C) modes at 2925 cm
1, 2852 cm1, 1455 cm1, 1350 cm1
and 1150 cm1, respectively, in Fig. 7a verifies the PSi particles have been modified with
ethylene glycol moieties, as shown before. The appearance of IR stretching at 1750
cm1 in Fig. 7b, ascribed to C]O, suggests successful activation of the distal hydroxyl
group of tetra(ethylene glycol) to a succinimide ester. After incubating the activated
particles in the anti-mouse IgG antibody solution for 2 h, the stretching of the C]O
bond disappeared. Instead, two broad peaks at 3380 cm1 and 1680 cm1 appeared
pointing to the presence of polypeptides, indicative of anti-mouse IgG coupling
on the PSi particles. In detail, there were two main peaks related to peptides
around the wavenumber of 3400 cm1: one at 3454 cm1 which is from the free
N–H stretch vibration and another peak at 3330 cm1 from the hydrogen-bonded
N–H stretch vibration.
Scheme 2 The formation of PSi Rugate filter microparticles and the surface chemistry used to
modify the microparticles with antibodies on the exterior surface.

















































Fluorescence images of PSi particles in Fig. 8 also support the successful immobi-
lization of Cy3-labeled antibody through covalent bonding. The micrographs in
Fig. 8a and b were taken from the same particles, but under different imaging modes:
fluorescence and white light epi-illumination, respectively. The fluorescence images
(Fig. 8a) show Cy3-labelled antibody across the entire PSi surface although it is
noted that there seems to be a higher density of antibody at the particle edges.
The particle edges are bare silicon, where no nonspecific protein adsorption resistant
chemistry is located, and hence the high fluorescence intensity may reflect nonspe-
cific adsorption of the antibodies.
Fig. 8 illustrates that antibody is immobilised onto the PSi microparticles but
provides no evidence of antibody functionality. To assess the binding capabilities
of surface-bound antibodies, the binding of free secondary antibody (AB2) to recog-
nize primary antibody-modified particles was examined here. In the method 1 of
antibody functionality test, mouse FITC-labeled anti-human CD3 primary antibody
was first covalently coupled onto PSi particles by the same chemistry approach in
Scheme 2. The particles were then incubated with two types of secondary antibody
(AB2): cyanine 3 affiniPure donkey anti-mouse IgG that should selectively bind to
the surface-bound, mouse anti-human CD3 primary antibodies and Cy3 AffiniPure
Fig. 7 Transmission-mode FTIR spectra of PSi microparticles at each step of immobilization.
(a) PSi particles with distal ethylene glycol groups on the exterior and distal octane groups
inside the pores. (b) DSC/DMAP-activated PSi particles. (c) Cy3-labeled antibody-coupled
PSi particles.
Fig. 8 (a) Fluorescence images of anti-mouse Cy3-labeled particles and (b) epi-illumination
images of the anti-mouse Cy3-labeled particles.

















































donkey anti-goat IgG as a control that should have no specific affinity for the
surface-bound antibodies.
Fluorescence images of the particles incubated with two different AB2 were taken
using a Leica DM IL microscope with a Cy3 filter and were quantified to compare
the fluorescence intensities, shown in Fig. 9. Both anti-goat and anti-mouse AB2-
incubated particles show some fluorescence (Fig. 9a and b), indicating some nonspe-
cific binding of anti-goat AB2 onto the PSi particles. However, based on a one-way
ANOVA analysis, anti-mouse AB2-bound particles have significantly higher fluores-
cence intensity than the control particles with anti-goat AB2 (Fig. 9c), in accordance
with the fact that only anti-mouse AB2 can specifically bind to the mouse-hosted
anti-human CD3 primary antibody. This result serves as a demonstration that the
binding epitopes of proteins immobilised on the PSi particles are preserved for
binding to other proteins, an essential criterion for targeting specific cell types.
Fig. 9 Comparison of the fluorescence intensities from anti-goat AB2-bound PSi particles and
anti-mouse AB2-bound particles. (a) and (b) fluorescence images of PSi particles with anti-goat
AB2 and anti-mouse AB2, respectively. (c) Statistical analysis of fluorescence emissions by anti-
body-bound particles. The asterisks represent significant difference based on a one-way AN-
OVA analysis, while *** stands for significance at 99.9% confidence interval.
Fig. 10 Comparison of the green fluorescence images (in black and white mode) from FITC-
labeled mouse anti-human CD3 AB-incubated PSi particles, which were modified with anti-
mouse AB2 (a) and anti-rabbit AB2 (b), respectively. Arrows display the position of particles.
Scale bar equals 50 mm.

















































To illustrate that antibodies bound to the particles remain capable of binding to
specific epitopes of cells, a second antibody test was performed. In method 2,
secondary antibodies, either Cy3-labeled anti-mouse AB2 or Cy3-labeled anti-rabbit
AB2 were immobilised on the PSi particle surface first for selective binding to free
primary antibodies in the solution. Fig. 10 shows the fluorescence micrographs of
two different AB2-modified PSi particles after incubating with FITC-labeled mouse
anti-human CD3 primary antibodies. With anti-mouse AB2, which specifically binds
the FITC-labeled anti-human CD3 primary antibody, the particles showed brighter
fluorescence than the reference ones with anti-rabbit AB2 which have no specific
affinity for the FITC-labeled anti-human CD3 primary antibody. Hence, this sup-
ported that the active binding sites on surface-bound antibodies maintain their func-
tionality.
4. Conclusions
The recent demonstration that porous silicon photonic crystals could be functional-
ised such that they capture cells32 and monitor the release of metalloprotease
enzymes from living macrophage cells26 highlighted the potential of this material
as a diagnostic/theranostic tool. This initial work showed label-free detection of
the release of enzymes from approximately 1500 cells but the concept could theror-
etically be applied to single-cell sensing. Here we have outlined the realisation of
many of the developments required to apply these ideas to single-cell sensing.
Here, we use a similar strategy as the original study by Kilian et al.34 but applied
it to PSi particles. It was necessary to show that the PSi particles could be chemically
modified such that the particles were stable in physiological media and could have
functional biorecognition molecules attached to give them selectivity for target cell
types. The fact that the PSi particles remained stable in physiological media for
over one week and that antibody-modified particles maintained the ability to selec-
tively bind their antigen illustrates that they can be used for the target application.
The study presented here takes us towards being able to perform selective binding
of PSi particles to single cells and monitor the release of protease enzymes from these
cells. To achieve the latter will require modifying the internal pore spaces of the PSi
particles with an enzyme-specific substrate, as we have done for macroscale pieces of
PSi. As the release of protease enzymes is up- or down-regulated by chemical agents,
such as therapeutics, these PSi particles could be used for monitoring the impact of
specific therapeutics on cell behaviour. This capability could then be used for moni-
toring drug efficacy and could be tailored to the cells of individuals, thus providing
patient specific information of the drug action and dosage requirements; the very
essence of theranostics.
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